Table 1.

General patient and cycle characteristics

							CultActive-treated group				Control group
	Patient’s age	Infertility	Suppression type	Sperm concentration (mil/ml)	% progressive and non-progressive motility	Nr COC	Nr MII	Nr 2PN	Nr ET	Nr EC	Nr MII	Nr 2PN	Nr ET	Nr EC
1	37	OAT	Antagonist	28.6	61	16	7	5	1	0	8	7	0	0
2	29	Idiopathic	Antagonist	58.5	42	4	2	1	0	0	2	2	1	0
3	26	OAT	Antagonist	13.5	58	12	6	4	0	0	6	6	0	2
4	40	OAT	Antagonist	38.7	30	5	2	0			3	2	0	1
5	36	Idiopathic	Antagonist	80.5	86	17	8	7	0	1	9	8	0	3
6	28	Idiopathic	Antagonist	57.5	60	15	8	6	0	1	7	1	0	1
7	30	PCOS	Antagonist	120.5	16	48	24	20	0	3	24	19	0	4
8	37	OAT	Agonist	0.24	17	6	3	3	1	0	3	3	1	0
9	32	Idiopathic	Antagonist	76.0	48	9	4	4	0	0	5	3	0	0
10	33	Endometriosis	Antagonist	13.5	34	12	6	5	1	0	6	5	0	0
11	35	Tubal	Agonist	114.0	77	10	5	4	0	0	5	3	0	0
12	33	Idiopathic	Antagonist	57.35	32	7	4	4	1	0	3	3	0	1
13	43	Age	Antagonist	38.4	48	6	3	3	1	0	3	1	1	0
14	41	Age	Antagonist	10.1	23	10	5	4	0	1	5	4	0	1
15	43	OAT	Antagonist	0.66	74	5	3	3	1	1	2	2	0	0
16	28	OAT	Antagonist	0.34	27	12	6	6	1	1	6	6	0	2
17	42	Andrologic	Agonist	32.7	71	13	6	6	0	1	7	6	1	1
18	37	Idiopathic	Antagonist	21.8	37	31	15	14	0	1	16	14	0	2
19	41	Age	Agonist	32.6	12	10	5	5	0	0	5	4	0	0

OAT, oligoasthenotheratospermia; PCOS, polycystic ovary syndrome; COC, cumulus-oocyte-complex. Semen parameters represent values before capacitation; MII, metaphase II oocyte; 2PN, fertilized oocytes; ET, embryos transferred; EC, embryos cryopreserved